Monument Capital Management Amgen Inc Transaction History

Monument Capital Management

$357 Million
Q4 2024

A detailed history of Monument Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Monument Capital Management holds 1,743 shares of AMGN stock, worth $497,487. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,743

Previous 2,102 17.08%

Holding current value

$497,487

Previous $677,000 32.94%

% of portfolio

0.13%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$258.78 - $328.31 $92,902 - $117,863	-359 Reduced 17.08%	1,743 $454,000
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $13,303 - $14,507	43 Added 2.09%	2,102 $677,000
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $26,537 - $32,250	-101 Reduced 4.68%	2,059 $643,000
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $20,434 - $24,666	-76 Reduced 3.4%	2,160 $614,000
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $16,876 - $19,038	66 Added 3.04%	2,236 $644,000
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $150,212 - $186,493	687 Added 46.33%	2,170 $583,000
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $180,843 - $213,844	-844 Reduced 36.27%	1,483 $329,000
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $18,740 - $22,841	83 Added 3.7%	2,327 $562,000
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $201,546 - $256,088	880 Added 64.52%	2,244 $0
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $28,730 - $32,403	128 Added 10.36%	1,364 $308,000
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $285,157 - $317,330	1,236 New	1,236 $301,000
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $469,754 - $537,591	-2,362 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $18,255 - $21,388	86 Added 3.78%	2,362 $502,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $531,628 - $589,802	2,276 New	2,276 $555,000
Q1 2021 Apr 12, 2021	SELL	$221.91 - $258.6 $2.12 Million - $2.47 Million	-9,548 Closed	0 $0
Q4 2020 Jan 15, 2021	BUY	$216.38 - $257.67 $160,770 - $191,448	743 Added 8.44%	9,548 $2.2 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $61,947 - $68,890	264 Added 3.09%	8,805 $2.24 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $18,198 - $22,332	-92 Reduced 1.07%	8,541 $2.01 Million
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $62,143 - $82,419	341 Added 4.11%	8,633 $1.75 Million
Q4 2019 Jan 14, 2020	BUY	$189.21 - $243.2 $12,487 - $16,051	66 Added 0.8%	8,292 $2 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $35,518 - $42,558	-204 Reduced 2.42%	8,226 $1.59 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $1.41 Million - $1.65 Million	8,430 New	8,430 $1.57 Million
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $2,319 - $2,707	-13 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $2,408 - $2,715	13 New	13 $3,000

Others Institutions Holding AMGN

# of Institutions

3,083

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Monument Capital Management with notifications on news.

Account

Monument Capital Management Amgen Inc Transaction History